These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 36788984)

  • 1. Epithelioid sarcoma and its outcome: a retrospective analysis from a tertiary care center in North India.
    Kashyap D; Rastogi S; Garg V; Shrivastava S; Barwad A; Shamim SA; Hemrom A; Dhamija E; Bhoriwal S; Garg R
    Future Sci OA; 2022 Oct; 8(9):FSO822. PubMed ID: 36788984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tazemetostat in advanced epithelioid sarcoma with loss of INI1/SMARCB1: an international, open-label, phase 2 basket study.
    Gounder M; Schöffski P; Jones RL; Agulnik M; Cote GM; Villalobos VM; Attia S; Chugh R; Chen TW; Jahan T; Loggers ET; Gupta A; Italiano A; Demetri GD; Ratan R; Davis LE; Mir O; Dileo P; Van Tine BA; Pressey JG; Lingaraj T; Rajarethinam A; Sierra L; Agarwal S; Stacchiotti S
    Lancet Oncol; 2020 Nov; 21(11):1423-1432. PubMed ID: 33035459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Experience with Advanced/Metastatic Epithelioid Sarcoma Patients Treated in Prospective Trials: Clinical Profile and Response to Systemic Therapy.
    Touati N; Schöffski P; Litière S; Judson I; Sleijfer S; van der Graaf WT; Italiano A; Isambert N; Gil T; Blay JY; Stark D; Brodowicz T; Marréaud S; Gronchi A
    Clin Oncol (R Coll Radiol); 2018 Jul; 30(7):448-454. PubMed ID: 29550245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epithelioid Sarcoma-From Genetics to Clinical Practice.
    Czarnecka AM; Sobczuk P; Kostrzanowski M; Spalek M; Chojnacka M; Szumera-Cieckiewicz A; Rutkowski P
    Cancers (Basel); 2020 Jul; 12(8):. PubMed ID: 32751241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early clinical and metabolic response to tazemetostat in advanced relapsed INI1 negative epithelioid sarcoma.
    Tansir G; Rastogi S; Shamim SA; Barwad A
    Future Sci OA; 2021 Jan; 7(4):FSO675. PubMed ID: 33815821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anthracycline, Gemcitabine, and Pazopanib in Epithelioid Sarcoma: A Multi-institutional Case Series.
    Frezza AM; Jones RL; Lo Vullo S; Asano N; Lucibello F; Ben-Ami E; Ratan R; Teterycz P; Boye K; Brahmi M; Palmerini E; Fedenko A; Vincenzi B; Brunello A; Desar IME; Benjamin RS; Blay JY; Broto JM; Casali PG; Gelderblom H; Grignani G; Gronchi A; Hall KS; Mir O; Rutkowski P; Wagner AJ; Anurova O; Collini P; Dei Tos AP; Flucke U; Hornick JL; Lobmaier I; Philippe T; Picci P; Ranchere D; Renne SL; Sbaraglia M; Thway K; Wagrodzki M; Wang WL; Yoshida A; Mariani L; Kawai A; Stacchiotti S
    JAMA Oncol; 2018 Sep; 4(9):e180219. PubMed ID: 29800950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tazemetostat for advanced epithelioid sarcoma: current status and future perspectives.
    Simeone N; Frezza AM; Zaffaroni N; Stacchiotti S
    Future Oncol; 2021 Apr; 17(10):1253-1263. PubMed ID: 33289402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gemcitabine and docetaxel versus doxorubicin as first-line treatment in previously untreated advanced unresectable or metastatic soft-tissue sarcomas (GeDDiS): a randomised controlled phase 3 trial.
    Seddon B; Strauss SJ; Whelan J; Leahy M; Woll PJ; Cowie F; Rothermundt C; Wood Z; Benson C; Ali N; Marples M; Veal GJ; Jamieson D; Küver K; Tirabosco R; Forsyth S; Nash S; Dehbi HM; Beare S
    Lancet Oncol; 2017 Oct; 18(10):1397-1410. PubMed ID: 28882536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical features and outcomes of young patients with epithelioid sarcoma: an analysis from the Children's Oncology Group and the European paediatric soft tissue Sarcoma Study Group prospective clinical trials.
    Spunt SL; Francotte N; De Salvo GL; Chi YY; Zanetti I; Hayes-Jordan A; Kao SC; Orbach D; Brennan B; Weiss AR; van Noesel MM; Million L; Alaggio R; Parham DM; Kelsey A; Randall RL; McCarville MB; Bisogno G; Hawkins DS; Ferrari A
    Eur J Cancer; 2019 May; 112():98-106. PubMed ID: 30954717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in the Efficacies of Pazopanib and Gemcitabine/Docetaxel as Second-Line Treatments for Metastatic Soft Tissue Sarcoma.
    Kim JH; Park HS; Heo SJ; Kim SK; Han JW; Shin KH; Kim SH; Hur H; Kim KS; Choi YD; Kim S; Lee YH; Suh JS; Ahn JB; Chung HC; Noh SH; Rha SY; Kim HS
    Oncology; 2019; 96(2):59-69. PubMed ID: 30336470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of palliative chemotherapy in advanced epithelioid sarcoma.
    Jones RL; Constantinidou A; Olmos D; Thway K; Fisher C; Al-Muderis O; Scurr M; Judson IR
    Am J Clin Oncol; 2012 Aug; 35(4):351-7. PubMed ID: 21422990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Good and sustained response to pembrolizumab and pazopanib in advanced undifferentiated pleomorphic sarcoma: a case report.
    Arora S; Rastogi S; Shamim SA; Barwad A; Sethi M
    Clin Sarcoma Res; 2020; 10():10. PubMed ID: 32670543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacotherapeutic strategies for epithelioid sarcoma: are we any closer to a non-surgical cure?
    Meissner M; Napolitano A; Thway K; Huang P; Jones RL
    Expert Opin Pharmacother; 2023; 24(12):1395-1401. PubMed ID: 37326105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proximal-type epithelioid sarcoma of vulva - Case series of a rare tumor.
    Dash B; Rekhi B; Shylasree TS; Maheshwari A; Bajpai J
    Gynecol Oncol Rep; 2022 Feb; 39():100921. PubMed ID: 35059488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epithelioid sarcoma in children and adolescents: a report from the Italian Soft Tissue Sarcoma Committee.
    Casanova M; Ferrari A; Collini P; Bisogno G; Alaggio R; Cecchetto G; Gronchi A; Meazza C; Garaventa A; Di Cataldo A; Carli M;
    Cancer; 2006 Feb; 106(3):708-17. PubMed ID: 16353216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical outcomes of patients with epithelioid sarcomas: impact and management of nodal metastasis.
    Outani H; Imura Y; Tanaka T; Takenaka S; Oshima K; Hamada K; Kakunaga S; Joyama S; Naka N; Kudawara I; Ueda T; Araki N; Yoshikawa H
    Int J Clin Oncol; 2018 Feb; 23(1):181-188. PubMed ID: 28799063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pazopanib in rare histologies of metastatic soft tissue sarcoma.
    Kataria B; Sharma A; Biswas B; Bakhshi S; Pushpam D
    Ecancermedicalscience; 2021; 15():1281. PubMed ID: 34824604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metastatic sclerosing epithelioid fibrosarcoma in an adult male from a tertiary care centre in India: a case report.
    Santhosh A; Mehta J; Barwad A; Shamim SA; Rastogi S
    Ecancermedicalscience; 2022; 16():1446. PubMed ID: 36405948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase II trial of pazopanib in patients with metastatic or unresectable chemoresistant sarcomas: A Japanese Musculoskeletal Oncology Group study.
    Urakawa H; Kawai A; Goto T; Hiraga H; Ozaki T; Tsuchiya H; Nakayama R; Naka N; Matsumoto Y; Kobayashi E; Okuma T; Kunisada T; Ando M; Ueda T; Nishida Y
    Cancer Sci; 2020 Sep; 111(9):3303-3312. PubMed ID: 32579783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ipsilateral breast metastasis after axillary dissection caused by epithelioid sarcoma: a case report and pathological investigation.
    Chen L; Wang L; Zhang X; Yao M; Fu P
    Diagn Pathol; 2019 Oct; 14(1):111. PubMed ID: 31615564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.